Study of effectiveness of topical phenytoin in healing of diabetic foot ulcers

Evaluation of the effectiveness of sodium phenytoin dressing on wound healing among the patients with Diabetic foot ulcer at Tata Motors Hospital,Jamshedpur - nil

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062560

Enrollment

Registered

2024-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E086- Diabetes mellitus due to underlying condition with other specified complications

Interventions

Intervention1: phenytoin dressing: 2ml phenytoin (100mg) in 5 ml NS applied once every 48 hours on the diabetic foot ulcer Intervention2: phenytoin dressing: 2ml phenytoin (100mg) in 5 ml NS applied

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients with diabetic foot ulcer irrespective of gender. 2. Both Inpatients and outpatients with Diabetic foot ulcer.

Exclusion criteria

Exclusion criteria: 1. Ulcers of other etiology. 2. Other comorbid conditions like renal failure, generalized debility which adversely affect wound healing. 3. Patients allergic to phenytoin . 4. patients who are immunocompromised or under immunosuppression therapy.

Design outcomes

Primary

Measure	Time frame
Incidence of complete ulcer healing.Timepoint: 8 weeks	—

Secondary

Measure	Time frame
Time to achieve complete wound closureTimepoint: 8 weeks;Percentage reduction total ulcer surface areaTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactPonnam Amarnadh

Tata Motors Hospital

Arunima.Verma@tatamotors.com9234653775

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026